Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06176534
Status:
RECRUITING
Last Update Posted:
2023-12-19
First Post:
2023-12-09
Brief Title:
Combination Followed by Maintenance Chemotherapy Versus CDK46 Inhibitor Combined With Endocrine Therapy for HR LowHER2-negative Advanced Breast Cancer a Prospective Randomized Open-label Phase Ⅱ Clinical Trial
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Organization Data
Organization:
Henan Cancer Hospital
Class:
OTHER_GOV
Study ID:
HNCH-MBC013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henan Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Min Yan MD
Responsible Party Title:
Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Henan Cancer Hospital
Old Name:
None
Old Organization:
None